Abstract
Merkel cell carcinoma (MCC) is a rare and lethal type ofskin cancer characterized by frequent recurrences and metastases. In view ofthe lack ofa proven treatment option for MCC, we immunochemically evaluated the presence ofMerkel cell polyomavirus (MCPyV), PD-1, PD-L1, CD8, and EZH2 on slides prepared from tumor tissues of13 patients with MCC, and examined their association with disease progression and overall survival. PD-1 was expressed on tumor infiltrating lymphocytes (TILs) in 92.3% ofthe patients. None ofthe tumor cells expressed PD-L1. CD8 levels were higher in MCPyV-positive tumors. Interestingly, higher CD8 levels correlated with better overall survival (p=0.025), while higher EZH2 expression correlated with metastasis/recurrence (z=-1.396, p=0.089). However, low EZH2 expression was associated with poor overall survival (χ2=3.745, Cramer V=0.537, p=0.086). These findings suggest that EZH2 plays a significant role in MCC and may be a promising therapeutic target.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Polish journal of pathology : official journal of the Polish Society of Pathologists
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.